Assignee
RIGERNA THERAPEUTICS SUZHOU CO LTD
CN·0 granted patents·3 pending applications·0 citations·filing 2024–2025
Top patents by PatentIndex Score
3 records- 0167US2026009030A1Compound for inhibiting agt gene expression, and pharmaceutical composition and use thereofRIGERNA THERAPEUTICS SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 0267US2026009029A1Compound for inhibiting expression of lpa gene, pharmaceutical composition and use thereofRIGERNA THERAPEUTICS SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 0338US2025161464A1Compound for inhibiting c3 gene expression, pharmaceutical composition and use thereofRIGERNA THERAPEUTICS SUZHOU CO LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RIGERNA THERAPEUTICS SUZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →